Analyzing morphological and physiological changes in oligodendrocye precursor cells (OPCs)/NG2 cells during development and in disease models. (This project is funded by the European Union’s Framework Program for Research and Innovation Horizon 2020 (2014–2020) under the Marie Sklodowska-Curie Grant Agreement No. 845336, "The role of NG2 cells in the neural network in health and disease", to Friederike Pfeiffer, and is performed in collaboration with the University of Connecticut)



Partners in Tübingen


Partners in Germany


Partners in Europe/USA



    • Department of Preclinical Imaging and Radiopharmacy (Prof. Pichler)
    • Hertie Institute for Clinical Brain Research (Prof. Jucker)
    • Interfaculty Institute for Biochemistry (Prof. Feil)
    • Department of Medical Genetics (Prof. Ries)


    • University of Bonn (Prof. Heneka) 
    • University of Heidelberg (Prof. Winkler)
    • MPI of Neurobiology, Martinsried (Dr. Griesbeck)
    • University of Jena (Prof. Holthoff)
    • University Medical Center Hamburg-Eppendorf (Prof. Fehse)


    • University of Southampton, UK (Prof. Perry & Dr. Gomez-Nicola) 
    • Lund University (Prof. Jakobsson)
    • Yale University, New Haven USA (Prof. Cohen)
    • University of Manchester, UK (Prof. Verkhratsky)
    • Precarpathian National University, Ukraine (Prof. Lushchak)
    • University of Nizhny Novgorod, Russia (Prof. Semyanov)